ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1582

The Association of Lupus Nephritis Histopathologic Classification with Venous Thromboembolism Is Modified by Age at Biopsy

Ian Cooley1, Vimal Derebail 1, Keisha Gibson 1, Carolina Alvarez 2, Caroline Poulton 1, Lauren Blazek 1, Andrew Love 1, Susan Hogan 1, Ronald Falk 1 and Saira Sheikh 3, 1University of North Carolina at Chapel Hill, Chapel Hill, 2University of North Carolina at Chapel Hill Thurston Arthritis Research Center, Chapel Hill, NC, 3University of North Carolina, Chapel Hill, NC

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: lupus nephritis and vte

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: SLE – Clinical Poster II: Comorbidities

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic lupus erythematosus (SLE) is a systemic autoimmune disease that is associated with an increased incidence of venous thromboembolism (VTE). Lupus nephritis (LN) has been shown to be an independent risk factor for VTE. To our knowledge the risk of VTE has not been studied by International Society of Nephrology/Renal Pathology Society (ISN/RPS) LN class.

Methods: A cross-sectional analysis was performed using data from the Glomerular Disease Collaborative Network (GDCN). Patients with class V LN were compared to those with class III or IV (but not associated class V) LN. Classes I, II and VI were excluded from analysis due to their low prevalence. The outcome of interest was image-confirmed VTE. Logistic regression was used to calculate odds ratios and 95% confidence intervals, adjusted for age, sex, race, hormonal contraception use, serum albumin and use of hydroxychloroquine. Effect modification was assessed between the main effect and other covariates and considered if p< 0.05.

Results: Our cohort consisted of 533 patients; 311 (58.3%) with class III/IV and 222 (41.7%) with class V LN. Mean±SD age was 30.9±15.0 years (range 6-79 years), with an overall incidence of image-confirmed VTE of 54/533 (10.1%). In adjusted analyses, the odds of VTE were not significantly different for those with class III/IV compared to class V LN (OR, 95% CI: 1.00, 0.54-1.84). There was, however, evidence of effect modification of LN class on VTE by age at biopsy, as displayed in table 1.

Conclusion: VTE was common in LN patients in the GDCN, occurring in ~10%, and its incidence was similar among patients with class III/IV LN and those with class V LN. These findings suggest that the association between LN and VTE is not limited to class V-related nephrotic syndrome. Interestingly, however, age-specific analysis demonstrated increased odds of VTE with class III/IV LN diagnosed at a younger age and decreased odds ratio for VTE with class III/IV LN diagnosed at an older age. This may suggest the presence of an age-sensitive modulation of LN class-specific VTE risk.


Table 1


Disclosure: I. Cooley, None; V. Derebail, Novartis, 5, Retrophin, 5, Retrophin, 2, Mallinckrodt, 2, Otsuka, 2, Chemocentryx, 2, Gilead, 2, Infla-RX, 2, American Society of Nephrology, 8, RTI International, 8, UpToDate, 8, University of North Carolina at Chapel Hill, 3; K. Gibson, Reata Inc, 5, Retrophin Inc, 2, Aurinia Inc, 2; C. Alvarez, None; C. Poulton, None; L. Blazek, None; A. Love, None; S. Hogan, None; R. Falk, None; S. Sheikh, GSK, 5.

To cite this abstract in AMA style:

Cooley I, Derebail V, Gibson K, Alvarez C, Poulton C, Blazek L, Love A, Hogan S, Falk R, Sheikh S. The Association of Lupus Nephritis Histopathologic Classification with Venous Thromboembolism Is Modified by Age at Biopsy [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/the-association-of-lupus-nephritis-histopathologic-classification-with-venous-thromboembolism-is-modified-by-age-at-biopsy/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-association-of-lupus-nephritis-histopathologic-classification-with-venous-thromboembolism-is-modified-by-age-at-biopsy/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology